TREM2 and neoplasm: Blocking TREM2 has shown promising anti-tumor effects in tumor patients and mouse models (20, 127) by reprogramming tumorigenic macrophages into anti-tumor macrophages, improving their impaired antigen presentation ability and inhibiting tumor growth (62, 128).